Impeding Access to Quality Patient Care and Patient Rights: How Myriad Genetics' Gene Patents are Unknowingly Killing Cancer Patients and How to Calm the Ripple Effect
Author(s)
Pins, Marisa NoelleKeywords
United States Patent and Trademark OfficeMyriad Genetics Laboratories
Inc.
University of Utah Research Foundation
gene patents
ACLU
patient care
DNA
utility requirement
utility examination guidelines
Diamond v. Chakrabarty
American Wood-Paper Co. v. Fiber Disintegrating Co.
European Patent Convention
National Institutes of Health
Best Practices for the Licensing of Genomic Inventions
Secretary's Advisory Committee on Genetics
Health
and Human Services
Organisation for Economic Co-Operation and Development
Bioethics and Medical Ethics
Genetics and Genomics
Health Law and Policy
Intellectual Property Law
Full record
Show full item recordOnline Access
https://digitalcommons.law.uga.edu/jipl/vol17/iss2/8https://digitalcommons.law.uga.edu/cgi/viewcontent.cgi?article=1274&context=jipl
Date
2016-06-14Type
textIdentifier
oai:digitalcommons.law.uga.edu:jipl-1274https://digitalcommons.law.uga.edu/jipl/vol17/iss2/8
https://digitalcommons.law.uga.edu/cgi/viewcontent.cgi?article=1274&context=jipl